Patent Yard Sign in
Expired Canadian patentCanada

Anti-ige vaccines

CA 2674838 C · Owner: Sheppard, Michael George · Inventors: Morsey, Mohamad Ali; Wheeler, David Walter; Sheppard, Michael George

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention provides compositions and methods for the use of antigenic peptides derived from the Fc portion of the epsilon heavy chain of an IgE molecule as vaccines for the treatment and prevention of IgE-mediated allergic disorders. In particular the invention provides compositions, methods for the treatment and prevention of IgE-mediated allergic disorders comprising an immunogenic amount of one or more antigenic peptides derived from the CH3 domain or junction of Ch-3/CH4 domain of an IgE molecule and methods for the evaluation of IgE mediated allergies in dogs.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed August 28, 2001 and granted February 18, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 28, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 28, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 28, 2001
GrantedFebruary 18, 2014
Term endedAugust 28, 2021
Patent numberCA 2674838 C
Classification (IPC)C12N15/13 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedAug 28, 2001Patent grantedFeb 18, 2014Term endedAug 28, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.